May 9, 2026 - 03:11

Microchip Technology (MCHP) has posted a year-to-date return of 53.77% as of early May, placing it among the top contenders for investors looking to beat the broader S&P 500 index. The chipmaker recently gave a bullish forecast for the first quarter, with revenue projections coming in above Wall Street estimates.
According to a Reuters report from May 7, the company is seeing strong demand for its semiconductors used in industrial and automotive applications. This surge in orders suggests that the non-AI chip market is finally shaking off a prolonged slump. For years, Microchip focused on general-purpose microcontrollers and analog chips, which are essential for everything from factory equipment to car electronics. That focus is now paying off as these sectors rebound.
The stock's performance raises a key question for investors: can Microchip sustain this momentum? The company's guidance indicates that inventory levels are normalizing and customers are placing new orders after a period of destocking. If this trend holds, Microchip could continue to deliver solid earnings growth.
However, beating the S&P 500 over the long term is no small feat. The index has its own powerful tailwinds from tech giants and AI leaders. Microchip's advantage lies in its diversified customer base and essential product lines that are less volatile than consumer-focused chip stocks. For now, the company's strong quarterly outlook and robust year-to-date gains make it a stock worth watching for anyone trying to outperform the market.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...